In GNC–siRNA-treated tumours, 5′-RACE analysis using human NGF gene-specific primers identified a PCR product of expected cleavage product with a molecular weight ∼370 bp (Fig. 7k). The gene discussed is NGF; the disease is gangliocytoma.